Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/PA/Scranton
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Scranton, PA

Studies commonly pay $75 to $4,500 per completed study

99 clinical trials are currently recruiting participants within 30 miles of Scranton. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

99studies recruiting
5+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Scranton right now

Top 25 of 99 recruiting studies, sorted by proximity — each links to its official registry page

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

Diffuse Large B-Cell Lymphoma, Grade 3b Follicular Lymphoma Phase 2 Interventional 396 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05633615)

Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer

Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Phase 3 Interventional 356 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06958328)

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 189 participants sought
Northeast Radiation Oncology Center — Dunmore, Pennsylvania (2.0 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT02734537)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 Phase 3 Interventional 228 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06992427)

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

Malignancy N/A Observational 240 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04242095)

Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment

Plasma Cell Myeloma Phase 3 Interventional 510 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT05561387)

Vitamin D for Prostate Endocrine Therapy

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8 Phase 3 Interventional 240 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: University of Rochester
See eligibility & contact on ClinicalTrials.gov (NCT05838716)

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

Geographic Atrophy Secondary to Age-related Macular Degeneration Phase 2 Interventional 240 participants sought
Eye Care Specialists — Kingston, Pennsylvania (15.6 mi) · Sponsor: Apellis Pharmaceuticals, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07215390)

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 Phase 3 Interventional 1,209 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05946213)

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Pancreatic Carcinoma, Pancreatic Neoplasm Phase 3 Interventional 274 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT06807437)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Northeast Radiation Oncology Center — Dunmore, Pennsylvania (2.0 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients

Non Small Cell Lung Cancer, Epidermal Growth Factor Receptor Gene Mutation N/A Observational 538 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: PrECOG, LLC.
See eligibility & contact on ClinicalTrials.gov (NCT06538038)

A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine

Lyme Disease Phase 3 Interventional 1,712 participants sought
Northeast Clinical Trials Group — Scranton, Pennsylvania (0.3 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT07500506)

Single-Arm Study of a Treatment for Dry Eye in People Who Struggle to Wear Contact Lenses

Dry Eye Phase 4 Interventional 30 participants sought
Eye Care Specialists — Kingston, Pennsylvania (15.6 mi) · Sponsor: Vision Innovation Centers of Pennsylvania, LLC d/b/a Eye Care Specialists
See eligibility & contact on ClinicalTrials.gov (NCT07510620)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma Phase 3 Interventional 1,273 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03678025)

Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

Meningococcal Infection N/A Observational 50 participants sought
Pennsylvania Locations — Swiftwater, Pennsylvania (27.7 mi) · Sponsor: Sanofi Pasteur, a Sanofi Company
See eligibility & contact on ClinicalTrials.gov (NCT04843111)

Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors

Hodgkin Lymphoma, Non-Hodgkin Lymphoma N/A Observational 2,000 participants sought
Community Medical Center — Scranton, Pennsylvania (0.3 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT06002828)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v8 Phase 3 Interventional 364 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05673148)

Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer

Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 1,100 participants sought
Geisinger Cancer Center Dickson City — Dickson City, Pennsylvania (5.5 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT06632327)

Left vs Left Randomized Clinical Trial

Heart Failure, Heart Failure With Reduced Ejection Fraction N/A Interventional 2,136 participants sought
Geisinger Commonwealth School of Medicine — Scranton, Pennsylvania (0.3 mi) · Sponsor: Baylor College of Medicine
See eligibility & contact on ClinicalTrials.gov (NCT05650658)

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma Phase 2 Interventional 188 participants sought
Geisinger Wyoming Valley/Henry Cancer Center — Wilkes-Barre, Pennsylvania (15.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04671667)
Actively enrolling

Studies you may be able to join near Scranton

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Scranton

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Northeast Clinical Trials Group (NECTR)

★ 5.0
802 Jefferson Ave, Scranton, PA 18510
(570) 504-5507

Altasciences

★ 4.2
130 Discovery Dr, Scott, PA 18447
(800) 300-8114

Lehigh Center for Clinical Research

★ 5.0
1245 S Cedar Crest Blvd, Allentown, PA 18103
(610) 820-0342
"Staff was very friendly and explained information to me in great detail"
— Virgilio Baello, 5★

Velocity Clinical Research

★ 4.5
4100 Vestal Rd Ste LL-100, Vestal, NY 13850
(607) 794-5790
"I've been waiting a week for them to pay me and I bet they're not even going to compensate me for the inconvenience of their ignorance. My old lady 6…"
— Obee Mcspanky, 2★

Geisinger Precision Health Center

★ 5.0
190 Welles St, Forty Fort, PA 18704
(570) 714-6420

Clinical trials in Scranton: what's recruiting

The Scranton area currently has 99 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Scranton, the most active research areas are:

  • Cancer & Oncology16 studies
  • Heart & Vascular4 studies
  • Lungs & Breathing1 studies
  • Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Scranton, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Scranton

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Scranton participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Scranton pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
How do I join a study in Scranton, PA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Is compensation for clinical trials taxable?
In the U.S., clinical trial compensation is generally considered taxable income, and research sites may issue a 1099 form for payments above $600 in a year. Reimbursements for travel or meals are typically treated differently. Consult a tax professional for your situation.
What is the difference between a research center and a hospital study in Scranton?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Scranton typically complete one or two studies per year.

Paid clinical trials near Scranton

Other metros within reach

Binghamton, NY21 Allentown, PA234 Reading, PA280 Trenton, NJ2,350 Philadelphia, PA2,177 Lancaster, PA431 Paterson, NJ4,141 Newark, NJ4,264

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Scranton Bladder Issues Due To Spinal Cord Injury in Scranton All conditions

More of PA

Philadelphia2,177 Pittsburgh1,232 York447 Lancaster431 Harrisburg402 Reading280 Allentown234 Erie89

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts